Table 1 Clinical classification of cases based on to single and paired serum sample algorithm
Study Group | n | Single Serum Sample, n (%) | Paired Serum Sample, n (%) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
Acute | Chronic | Early | Acute | Reactivation | Recent | Possible congenital infection | Passive immunity from mother | Latent | ||
Clinical Classification based on Serological Findings | ||||||||||
Pregnant Women | 82 | 7 (8.5) | 75 (91.5) | – | 2 (2.4) | 13 (15.8) | 5 (6.1) | – | – | 62 (75.6) |
Newborn and Infant | 141 | 3 (2.1) | 138 (97.9) | – | 3 (2.1) | – | – | 6 (4.3) | 132 (93.6) | – |
Child > 1 years old | 8 | – | 8 (100) | – | – | 2 (25.0) | – | – | – | 6 (75.0) |
Immunocompromised | 66 | 2 (3.0) | 64 (97.0) | – | 2 (3.0) | 29 (43.9) | – | – | – | 35 (53.0) |
Ocular Toxoplasmosis | 50 | 2 (4.0) | 48 (96.0) | 2 (4.0) | 1 (2.0) | 16 (32.0) | 1 (2.0) | – | – | 30 (60.0) |
Mother | 135 | 2 (1.5) | 133 (98.5) | 1 (0.7) | 1 (0.7) | 5 (3.7) | 1 (0.7) | – | – | 127 (94.1) |
Suggestive of active cases | 482 | Yes | No | Yes | Yes | Yes | Yes | Yes | No | No |
16 (3.3) | 466 (96.7) | 90 (18.7) | 392 (81.3) | |||||||
Treatment Initiation based on Serological and Clinical Findings | ||||||||||
Pregnant Women | 82 | 2/7 | 1/75 | – | 2/2 | 2/13 | 0/5 | – | – | 0/62 |
Newborn and Infant | 141 | 3/3 | 0/138 | – | 3/3 | – | – | 0/6 | 0/132 | – |
Child > 1 years old | 8 | – | 1/8 | – | – | 1/2 | – | – | – | 0/6 |
Immunocompromised | 66 | 2/2 | 29/64 | – | 2/2 | 29/29 | – | – | – | 2/35 |
Immunocompetent | 185 | 3/4 | 16/181 | 3/3 | 2/2 | 11/21 | 1/2 | – | – | 3/157 |
Ocular | 50 | 2/2 | 16/48 | 2/2 | 1/1 | 11/16 | 1/1 | – | – | 3/30 |
Mother | 135 | 1/2 | 0/133 | 1/1 | 1/1 | 0/5 | 0/1 | – | – | 0/127 |
Treatment initiation based on serology and clinical findings | 482 | 10 (2.1) | 47 (9.8) | 56 (11.6) | 5 (1.0) | |||||